NCT07013058View on ClinicalTrials.gov

Evaluation of a Nigella Sativa Extract (10% Thymoquinone, Nisatol®) in Perimenopausal Women With Metabolic Syndrome

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 15, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Metabolic SyndromeElevated Blood Pressure
Interventions
DIETARY_SUPPLEMENT

Nigella sativa extract (Nisatol®)

Participants will take 2 softgel capsules daily of Nigella sativa oil standardized to 10% thymoquinone (Nisatol®), one capsule with lunch and one with dinner, for 4 months.

BEHAVIORAL

Mediterranean Diet

Participants will follow a Mediterranean diet for 4 months under dietary guidance, without receiving any Nigella sativa supplementation.

Trial Locations (1)

03100

ASL Frosinone, Dipartimento di Prevenzione,, Frosinone

All Listed Sponsors
collaborator

"University of Urbino Carlo Bo"

OTHER

lead

Liaquat University of Medical & Health Sciences

OTHER